Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?

European Journal of Cancer

Volumn 48, Issue 12, 2012, Pages 1766-1773

  Walter, Thomas ^a,b,c   Chardon, Laurence ^a,b,c   Chopin Laly, Xavier ^a   Raverot, Véronique ^d   Caffin, Anne Gaelle ^a,c   Chayvialle, Jean Alain ^a,b,c   Scoazec, Jean Yves ^a,b,c   Lombard Bohas, Catherine ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

Carcinoid tumours; Chromogranin A; Neuroendocrine tumours; Polypeptide pancreatic; Surrogate marker

Indexed keywords

CHROMOGRANIN A; PANCREAS POLYPEPTIDE;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOGRANIN A; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PANCREATIC POLYPEPTIDE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84864127592     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.11.005     Document Type: Article

References (35)

1. D. O'Toole, A. Grossman, and D. Gross ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers Neuroendocrinology 90 2009 194 202
2. I.M. Modlin, B.I. Gustafsson, and S.F. Moss Chromogranin A - biological function and clinical utility in neuroendocrine tumor disease Ann Surg Oncol 17 2010 2427 2443
3. P. Tomassetti, M. Migliori, and P. Simoni Diagnostic value of plasma chromogranin A in neuroendocrine tumours Eur J Gastroenterol Hepatol 13 2001 55 58
4. D. Campana, F. Nori, and L. Piscitelli Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol 25 2007 1967 1973
5. E. Baudin, A. Gigliotti, and M. Ducreux Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours Br J Cancer 78 1998 1102 1107
6. E. Baudin, J.M. Bidart, and A. Bachelot Impact of chromogranin A measurement in the work-up of neuroendocrine tumors Ann Oncol 12 Suppl. 2 2001 S79 S82
7. M.C. Zatelli, M. Torta, and A. Leon Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study Endocr Relat Cancer 14 2007 473 482
8. E. Bajetta, L. Ferrari, and A. Martinetti Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors Cancer 86 1999 858 865
9. C.M. Korse, J.M. Bonfrer, N.K. Aaronson, A.A. Hart, and B.G. Taal Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine tumors Neuroendocrinology 89 2009 296 301
10. C.M. Korse, B.G. Taal, C.A. de Groot, R.H. Bakker, and J.M. Bonfrer Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor J Clin Oncol 27 2009 4293 4299
11. R. Arnold, A. Wilke, and A. Rinke Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors Clin Gastroenterol Hepatol 6 2008 820 827
12. J.C. Yao, C. Lombard-Bohas, and E. Baudin Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial J Clin Oncol 28 2010 69 76
13. S. Massironi, D. Conte, and V. Sciola Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors Am J Gastroenterol 105 2010 2072 2078
14. D. Nehar, C. Lombard-Bohas, and S. Olivieri Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours Clin Endocrinol (Oxf) 60 2004 644 652
15. A. Abou-Saif, F. Gibril, and J.V. Ojeaburu Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas Cancer 98 2003 249 261
16. M. Stivanello, A. Berruti, and M. Torta Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience Ann Oncol 12 Suppl. 2 2001 S73 S77
17. E. Seregni, L. Ferrari, E. Bajetta, A. Martinetti, and E. Bombardieri Clinical significance of blood chromogranin A measurement in neuroendocrine tumours Ann Oncol 12 Suppl. 2 2001 S69 S72
18. G. Schurmann, U. Raeth, B. Wiedenmann, H. Buhr, and C. Herfarth Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract World J Surg 16 1992 697 701 discussion 701-702
19. D. Vezzosi, T. Walter, and A. Laplanche Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study Int J Biol Markers 26 2011 94 101
20. A. Leon, M. Torta, and R. Dittadi Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational study Int J Biol Markers 20 2005 156 168
21. S.R. Bloom, T.E. Adrian, and J.M. Polak Pancreatic polypeptide from pancreatic endocrine tumours Lancet 2 1980 1026
22. K. Oberg, L. Grimelius, G. Lundqvist, and L.E. Lorelius Update on pancreatic polypeptide as a specific marker for endocrine tumours of the pancreas and gut Acta Med Scand 210 1981 145 152
23. T.E. Adrian, L.O. Uttenthal, S.J. Williams, and S.R. Bloom Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors N Engl J Med 315 1986 287 291
24. F. Panzuto, C. Severi, and R. Cannizzaro Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors J Endocrinol Invest 27 2004 6 11
25. G. Rindi, G. Kloppel, and H. Alhman TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Virchows Arch 449 2006 395 401
26. G. Rindi, G. Kloppel, and A. Couvelard TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system Virchows Arch 451 2007 757 762
27. M. Stridsberg, B. Eriksson, K. Oberg, and E.T. Janson A comparison between three commercial kits for chromogranin A measurements J Endocrinol 177 2003 337 341
28. G.P. Bernini, A. Moretti, and M. Ferdeghini A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours Br J Cancer 84 2001 636 642
29. F.R. Nobels, D.J. Kwekkeboom, and W. Coopmans Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones J Clin Endocrinol Metab 82 1997 2622 2628
30. L. Giovanella, S. La Rosa, and L. Ceriani Chromogranin-A as a serum marker for neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings Int J Biol Markers 14 1999 160 166
31. R.A. Pirker, J. Pont, and R. Pohnl Usefulness of chromogranin A as a marker for detection of relapses of carcinoid tumours Clin Chem Lab Med 36 1998 837 840
32. A.R. Moattari, L.J. Deftos, and A.I. Vinik Effects of sandostatin on plasma chromogranin-A levels in neuroendocrine tumors J Clin Endocrinol Metab 69 1989 902 905
33. B. Eriksson, K. Oberg, and M. Stridsberg Tumor markers in neuroendocrine tumors Digestion 62 Suppl. 1 2000 33 38
34. G.A. Kaltsas, G.M. Besser, and A.B. Grossman The diagnosis and medical management of advanced neuroendocrine tumors Endocr Rev 25 2004 458 511
35. T. Walter, L. Chardon, and V. Hervieu Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases Eur J Endocrinol 161 2009 639 645